Earnings summaries and quarterly performance for MGP INGREDIENTS.
Executive leadership at MGP INGREDIENTS.
Board of directors at MGP INGREDIENTS.
Research analysts who have asked questions during MGP INGREDIENTS earnings calls.
Marc Torrente
Wells Fargo
6 questions for MGPI
Mitchell Pinheiro
Sturdivant & Company
6 questions for MGPI
Sean McGowan
ROTH Capital Partners
6 questions for MGPI
Seamus Cassidy
TD Cowen
5 questions for MGPI
Benjamin Klieve
Lake Street Capital Markets
3 questions for MGPI
Ben Klieve
Lake Street Capital Markets
3 questions for MGPI
William Chappell
Truist Securities
3 questions for MGPI
Bill Chappell
Truist Securities
1 question for MGPI
Robert Moskow
TD Cowen
1 question for MGPI
Recent press releases and 8-K filings for MGPI.
- MGPI reported a 23% decrease in consolidated sales to $138 million and a 51% decrease in adjusted EBITDA to $26 million for Q4 2025, with a net loss of $135 million primarily due to a $153 million non-cash adjustment. For 2026, the company projects net sales of $480 million-$500 million, adjusted EBITDA of $90 million-$98 million, and adjusted basic EPS of $1.50-$1.80.
- The Branded Spirits segment saw premium plus sales increase 10% in Q4 2025, driven by 80% growth in Penelope Bourbon sales for the 52-week period ending December 27th, and plans to rationalize 20% of its tail brands. The Distilling Solutions segment declined 47% in sales in Q4 2025 and is expected to be down 35% in sales for 2026, while Ingredient Solutions is forecasted to recover with sales of $140 million-$150 million.
- The company expects a $111 million earnout payment for the Penelope acquisition in Q2 2026 and plans to refinance $201 million of convertible notes in Q4 2026, projecting net debt leverage to peak at approximately 3.75 times in Q2 2026.
- MGP Ingredients (MGPI) reported a 23% decrease in consolidated sales to $138.3 million for Q4 2025 and a 24% decrease to $536.4 million for the full year 2025.
- Full-year 2025 adjusted EBITDA decreased 41% to $116.0 million, and adjusted EPS decreased 49% to $2.85.
- The company provided 2026 guidance, projecting sales between $480 million and $500 million, adjusted EBITDA between $90 million and $98 million, and adjusted basic EPS between $1.50 and $1.80.
- Cash flows from operations increased by 19% to $121.5 million for 2025, a record high for MGP, and the net debt leverage ratio remained stable at 2.0x as of December 31, 2025.
- MGP Ingredients reported Q4 2025 consolidated sales of $138 million, a 23% decline year-over-year, with Adjusted EBITDA at $26 million and Adjusted Basic EPS at $0.63. For the full year 2025, consolidated sales were $536 million, Adjusted EBITDA was $116 million, and Adjusted Basic EPS was $2.85.
- The company provided 2026 guidance, projecting net sales in the $480 million-$500 million range, Adjusted EBITDA between $90 million-$98 million, and Adjusted Basic EPS in the $1.50-$1.80 range. Management expects Q1 2026 to be the lowest quarter for adjusted EBITDA, representing approximately 15% of the full year target.
- In the Branded Spirits segment, Q4 sales declined 1%, but Premium Plus sales grew 10%, significantly driven by Penelope Bourbon's 80% sales increase. The company plans to rationalize 20% of its tail brands and increase Branded Spirits A&P to 13.5% of segment sales in 2026.
- Distilling Solutions sales declined 47% in Q4 2025 and are projected to be down 35% in 2026, while Ingredient Solutions sales declined 10% in Q4 but are expected to see strong double-digit growth in 2026, with sales in the $140 million-$150 million range.
- MGP Ingredients anticipates a $111 million earnout payment for the Penelope acquisition in Q2 2026, which is expected to cause net debt leverage to peak at approximately 3.75 times. Despite lower earnings, full year 2025 operating cash flows increased 19% to $122 million.
- MGP Ingredients reported Q4 2025 consolidated sales declined 23% and Adjusted Basic EPS was $0.63, with full-year 2025 consolidated sales of $536 million and Adjusted Basic EPS of $2.85.
- The company issued 2026 guidance, projecting net sales in the $480 million-$500 million range, Adjusted EBITDA between $90 million-$98 million, and Adjusted Basic EPS of $1.50-$1.80, anticipating another challenging year for the industry and the company.
- Despite overall industry headwinds, the Premium Plus portfolio, led by Penelope Bourbon, demonstrated strong growth, with Penelope's dollar sales increasing 80% in the 52-week period ending December 27th.
- The Distilling Solutions segment is expected to see sales decline 35% in 2026, while the Ingredient Solutions business is poised for recovery with strong double-digit sales growth after a tough 2025.
- MGP Ingredients reported a 23% year-over-year decline in consolidated sales for the fourth quarter, despite beating revenue and adjusted EPS estimates.
- The company issued a downbeat 2026 outlook, forecasting net sales of approximately $480–$500 million and adjusted EPS around $1.65, which both missed analyst expectations and contributed to a roughly 21% drop in the stock.
- Management anticipates 2026 will be a trough year with peak net-debt leverage near 3.75x, and expects Distilling Solutions sales to fall roughly 35%.
- Despite the sharp fourth-quarter consolidated sales decline, MGP stated its 2025 performance actually exceeded the top end of its guidance.
- MGP Ingredients reported a net loss of $134.6 million for Q4 2025 and $107.8 million for full-year 2025, primarily due to a $152.6 million non-cash adjustment to goodwill and indefinite-lived intangible assets in the Branded Spirits segment.
- Consolidated sales decreased 23% to $138.3 million in Q4 2025 and 24% to $536.4 million for the full year, mainly due to lower brown goods sales in the Distilling Solutions segment and operational issues in Ingredient Solutions.
- Despite the net loss, the company generated a record-high cash flow from operations of $121.5 million for full-year 2025, an increase of $19.3 million from the prior year.
- For 2026, MGP Ingredients anticipates sales between $480 million and $500 million, adjusted EBITDA between $90 million and $98 million, and adjusted basic EPS in the $1.50 to $1.80 range.
- MGP Ingredients reported a 24% decrease in full-year 2025 consolidated sales to $536.4 million and a 49% decrease in adjusted basic EPS to $2.85 per share compared to 2024.
- The company incurred a net loss of $107.8 million for full-year 2025, primarily due to a $152.6 million non-cash adjustment to goodwill and indefinite-lived intangible assets.
- Despite lower net income, cash flow from operations increased to a record-high $121.5 million for full-year 2025.
- For 2026, MGP Ingredients projects sales in the range of $480 million to $500 million, adjusted EBITDA between $90 million and $98 million, and adjusted basic EPS in the $1.50 to $1.80 range.
- MGP Ingredients reported a decline in Q3 2025 net income to $15.23 million and revenue by 18.9% to $130.91 million compared to the previous year, although adjusted EPS of $0.85 exceeded Wall Street expectations.
- The company maintained its full-year revenue guidance at approximately $530 million (with slightly lowered expectations) and raised its adjusted EPS guidance to $2.68.
- While the operating margin declined to 16.1% in Q3 2025 from 20.2% in the prior year, the free cash flow margin improved to 21.1% from 15.2%.
- Operational challenges were noted in the Ingredient Solutions segment, but the company emphasized strong cash flow generation and a manageable net debt leverage ratio of approximately 1.8x.
- MGP Ingredients declared a quarterly dividend of $0.12 per share payable on November 28, 2025.
- For Q3 2025, MGP Ingredients reported consolidated sales decreased 19% to $131 million, with adjusted EBITDA declining to $32 million and adjusted basic earnings per share at $0.85.
- The company raised its full-year 2025 adjusted EBITDA guidance to $110 million to $115 million and adjusted EPS guidance to $2.60 to $2.75, while tightening sales guidance to $525 million to $535 million.
- The branded spirits segment sales decreased 3%, though Penelope Bourbon continued strong growth, ranking as the second fastest-growing premium plus American whiskey brand over the last 52 weeks.
- The distilling solutions segment sales declined 43%, and the ingredient solutions segment faced operational execution issues due to an unanticipated equipment outage, which is expected to remain a headwind in Q4.
- MGP Ingredients is conducting an exhaustive strategic review of its business and appointed Matthias Bentel as Chief Marketing Officer and Chris Wiseman as Senior Vice President of Operations.
- MGP Ingredients reported Q3 2025 consolidated sales of $131 million, a 19% decline, with adjusted EBITDA of $32 million and adjusted basic EPS of $0.85.
- The company raised its full-year 2025 guidance for adjusted EBITDA to $110 million-$115 million and adjusted EPS to $2.60-$2.75, while tightening sales guidance to $525 million-$535 million.
- Operational execution in the Ingredient Solutions segment fell short of expectations due to an unanticipated equipment outage and lower reliability, which is expected to remain a headwind in Q4 2025. Despite this, the Penelope Bourbon brand continues to drive strong performance in the branded spirits segment, ranking as the second fastest-growing premium plus American whiskey brand over the past 52 weeks.
- New leadership appointments include Matias Bentel as Chief Marketing Officer and Chris Wiseman as Senior Vice President of Operations.
Quarterly earnings call transcripts for MGP INGREDIENTS.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more